Morgan Stanley M Dx Health Sa Transaction History

Morgan Stanley

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	SELL	$2.69 - $3.86 $3,349 - $4,805	-1,245 Reduced 20.67%	4,779 $13,000
Q2 2023 Aug 14, 2023	BUY	$3.07 - $4.2 $18,493 - $25,300	6,024 New	6,024 $20,000
Q1 2022 May 13, 2022	SELL	$7.69 - $10.27 $11,734 - $15,672	-1,526 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$8.45 - $12.0 $12,894 - $18,312	1,526 New	1,526 $15,000

9.5K

Ticker MDXH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,288,100
Market Cap $35.3M
Description
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, the Netherlands, Belgium, Spain, Poland, Italy, rest of European Union, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which prov...

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

Stay updated on Morgan Stanley with notifications on news.